業績

片平じゅん

2018年以降の業績

（全業績はhttps://www.researchgate.net/profile/Jun-Katahiraをご覧ください）

  1. *Nagamori, I., Kobayashi, H., Nishimura, T., Yamagishi, R., Katahira, J., Kuramochi-Miyagawa, S., Kono, T., *Nakano, T. Relationship between PIWIL4-mediated H3K4me2 demethylation and piRNA-dependent DNA methylation. Cell Rep., 25, 350-356. (2018)
  1. *Katahira, J., Ishikawa, H., Tsujimura, K., Kurono, S., Hieda, M. Human THO coordinates transcription termination and subsequent transcript release from the HSP70 locus. Genes Cells, 24, 272-283 (2019)
  1. *Katahira, J., Senokuchi, K., Hieda, M. Human THO maintains the stability of repetitive DNA.

Genes Cells, 25, 334-342 (2020)

  1. Satomi, E., Ueda, M., *Katahira, J., *Hieda, M. The SUN1 splicing variant SUN1_888 and SUN1_916 differentially regulate nucleolar structure. Genes Cells, 25, 730-740 (2020)

松原三佐子

著書および学術論文

  1. Hieu VN, Thuy LTT, Hai H, Dat NQ, Hoang DV, Hanh NV, Phuong DM, Hoang TH, Sawai H, Yoshitsugu S, Sato-Matsubara M, Oikawa D, Tokunaga F, Yoshizato K, Kawada N*. Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion Redox Biology. 2022, Vol 52,102286.
  2. Takada S, Matsubara T*, Fujii H, Sato-Matsubara M, Daikoku A, Odagiri N, Amano-Teranishi Y, Kawada N, Ikeda K. Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. Lab Invest. 2021;101(2):193-203.
  3. Dat, NQ, Thuy LTT, Hieu VN, Hai H, Hoang DV, Hai NTT, Thuy TTV, Komiya T, Rombouts K, Dong MP, Hanh NV, Hoang TH, Sato-Matsubara M, Daikoku A, Kadono C, Oikawa D, Yoshizato K, Tokunaga F, Pinzani M, Kawada N*. (2021). Hexa Histidine-Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species. Hepatology 73(6): 2527-2545.
  4. Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N*. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol. 2021;27(3):413-424.
  5. 松原三佐子、吉里則文、河田則文*、抗線維化薬開発の最新情報、総説、日本消化器病学会誌　2020 117(1) 52-63. ・
  6. Okina Y, Sato-Matsubara M, Matsubara T, Daikoku A, Longato L, Rombouts K, Thanh Thuy LT, Ichikawa H, Minamiyama Y, Kadota M, Fujii H, Enomoto M, Ikeda K, Yoshizato K, Pinzani M, Kawada N*. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. J Hepatol. 2020;73(4):882-895. (共同筆頭著者)　
  7. 松原三佐子、吉里則文、河田則文*、肝星細胞活性化と肝硬変・肝がん、細胞、肝星細胞の活性化の仕組み、サイトグロビンの作用から見えてくる新しい視点、2019 51(11) 530-534.
  8. Kozuka R, Enomoto M, Sato-Matsubara M, Yoshida K, Motoyama H, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Tamori A, Kawada N, Murakami Y*. Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment. J Gastroenterol Hepatol. 2019 May;34(5):937-946.　
  9. Thi Thanh Hai N, Thuy LTT, Shiota A, Kadono C, Daikoku A, Hoang DV, Dat NQ, Sato-Matsubara M, Yoshizato K, Kawada N*. Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice. Sci Rep. 2018 Dec 14;8(1):17860.
  10. 松原三佐子、河田則文*、肝硬変、肝線維化、肝疾患における新薬開発の動向　消化器疾患の最新医療、先端医療シリーズ 2018, 49, 214-219.
  11. Sato-Matsubara M, Matsubara T, Daikoku A, Okina Y, Longato L, Rombouts K, Thuy LTT, Adachi J, Tomonaga T, Ikeda K, Yoshizato K, Pinzani M, Kawada N*. Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling. J Biol Chem. 2017;292(46):18961-18972.
  12. Matsuura K, Sawai H, Ikeo K, Ogawa S, Iio E, Isogawa M, Shimada N, Komori A, Sato-Matsubara M, *Tanaka Y.「他25名」Genome-wide association study identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus infection. Gastroenterology 2017,52:1383-1394.
  13. 松原三佐子、河田則文*、サイトグロビンと肝疾患　医学のあゆみ：TOPICS, 2017, 261, 829-830